13 results
·
24ms
·
Sources: EU EUDAMED, US FDA
Profoject Disposable Needle
FDA 510(k)
FDA Class 2
·General Hospital
SUPER QUICKANCHOR PLUS (WITH ORTHOCORD SUTURE)
FDA 510(k)
FDA Class 2
·Orthopedic
MPO Total Knee Systems MR Labeling
FDA 510(k)
FDA Class 2
·Orthopedic
BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR
FDA Adverse Event
Malfunction
·BECTON DICKINSON DE MEXICO·Product code JSH·September 3, 2025
JUVEDERM VOLUMA WITH LIDOCAINE 1 ML
FDA Adverse Event
Injury
·ALLERGAN·Product code LMH·November 5, 2014
IVT DISPOSABLE
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - MALTA·Product code KPE·September 18, 2011
NEW LIGASURE 5MM
FDA Adverse Event
Malfunction
·COVIDIEN LP·Product code GEI·July 15, 2013
BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR
FDA Adverse Event
Malfunction
·BECTON DICKINSON DE MEXICO·Product code JSH·October 4, 2024
BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR
FDA Adverse Event
Malfunction
·BECTON DICKINSON DE MEXICO·Product code JSH·July 7, 2023
PLATE BBL CHROMAGAR CANDIDA 100MM
FDA Adverse Event
Malfunction
·BECTON DICKINSON DE MEXICO·Product code JSI·September 13, 2021
VISTASEAL DUAL APPLICATOR
FDA Adverse Event
Malfunction
·ETHICON INC.·Product code MZM·April 6, 2021
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014